Myxoma Virus Expressing Human Interleukin-12 Does Not Induce Myxomatosis in European Rabbits
- 15 November 2007
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (22) , 12704-12708
Abstract
Myxoma virus (MV) is a candidate for oncolytic virotherapy due to its ability to selectively infect and kill tumor cells, yet MV is a species-specific pathogen that causes disease only in European rabbits. To assess the ability of MV to deliver cytokines to tumors, we created an MV (vMyxIL-12) that expresses human interleukin-12 (IL-12). vMyxIL-12 replicates similarly to wild-type MV, and virus-infected cells secrete bioactive IL-12. Yet, vMyxIL-12 does not cause myxomatosis, despite expressing the complete repertoire of MV proteins. Thus, vMyxIL-12 exhibits promise as an oncolytic candidate and is safe in all known vertebrate hosts, including lagomorphs.Keywords
This publication has 40 references indexed in Scilit:
- Oncolytic Virotherapy Synergism with Signaling Inhibitors: Rapamycin Increases Myxoma Virus Tropism for Human Tumor CellsJournal of Virology, 2007
- Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSFMolecular Therapy, 2006
- Angiogenesis Inhibition by an Oncolytic Herpes Virus Expressing Interleukin 12Clinical Cancer Research, 2004
- Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genesCellular Microbiology, 2004
- Lessons in Détente or know thy host: The immunomodulatory gene products of myxoma virusJournal of Biosciences, 2003
- Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse modelCancer Gene Therapy, 2001
- Cytokine Gene Transfer Enhances Herpes Oncolytic Therapy in Murine Squamous Cell CarcinomaHuman Gene Therapy, 2001
- M11lJournal of Experimental Medicine, 2000
- Interferon-?? Production by T Lymphocytes from Renal Cell Carcinoma Patients: Evidence of Impaired Secretion in Response to Interleukin-12Journal of Immunotherapy, 1999
- MyxomatosisJournal of Animal Ecology, 1966